Cytotoxic Flavonoids as Agonists of Peroxisome Proliferator-Activated Receptor γ on Human Cervical and Prostate Cancer Cells

被引:18
作者
Lee, Jee-Young [1 ,2 ]
Kim, Jin-Kyoung [1 ,2 ]
Cho, Min-Chul [1 ,2 ]
Shin, Soyoung [1 ,2 ]
Yoon, Do-Young [1 ,2 ]
Heo, Yong Seok [3 ]
Kim, Yangmee [1 ,2 ]
机构
[1] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea
[2] Konkuk Univ, Bio Mol Informat Ctr, Seoul 143701, South Korea
[3] Konkuk Univ, Dept Chem, Seoul 143701, South Korea
来源
JOURNAL OF NATURAL PRODUCTS | 2010年 / 73卷 / 07期
关键词
PPAR-GAMMA; NUCLEAR RECEPTORS; FLEXIBLE DOCKING; LIGAND-BINDING; METABOLISM; ALPHA; SELECTIVITY; MINIREVIEW; DISEASE; TARGETS;
D O I
10.1021/np100148m
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
We conducted in silico screening for human peroxisome proliferator-activated receptor gamma (hPPAR gamma) by performing in automated docking study with 450 flavonoids. Among the eight flavonoids is possible agonises of hPPAR gamma, only 3,6-dihydroxyflavone (4) increased the binding between PPAR gamma and steroid receptor coactivator-I (SRC-I), approximately 5-fold, and showed one order higher binding affinity for PPAR gamma than a reference compound, indomethacin. The 6-hydroxy group or the A-ring of 3,6-dihydroxyflavone (4) participated in hydrogen-bonding interactions with the side chain of Tyr327, His449, and Tyr473. The B-ring formed a hydrophobic interaction with Leu330, Leu333, Val339, Ile341, and Met364. Therefore, 3,6-dihydroxyflavone is a potent agonise of hPPAR with cytotoxic effects on human cervical and prostate cancer cells.
引用
收藏
页码:1261 / 1265
页数:5
相关论文
共 37 条
[1]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[2]   PPARs: therapeutic targets for metabolic disease [J].
Berger, JP ;
Akiyama, TE ;
Meinke, PT .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (05) :244-251
[3]  
Bocher V, 2002, ANN NY ACAD SCI, V967, P7
[4]   Green Tea: Nature's Defense against Malignancies [J].
Butt, Masood Sadiq ;
Sultan, Muhammad Tauseef .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2009, 49 (05) :463-473
[5]   Flavonoids: Prospective Drug Candidates [J].
Cazarolli, Luisa Helena ;
Zanatta, Leila ;
Alberton, Elga Heloisa ;
Reis Bonorino Figueiredo, Maria Santos ;
Folador, Poliane ;
Damazio, Rosangela Guollo ;
Pizzolatti, Moacir Geraldo ;
Mena Barreto Silva, Fatima Regina .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (13) :1429-1440
[6]   Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy [J].
Chinetti-Gbaguidi, G ;
Fruchart, JC ;
Staels, B .
CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) :177-183
[7]   5-(3,5-Di-tert-butyl-4-hydroxybenzylidene) thiazolidine-2,4-dione modulates peroxisome proliferators-activated receptor γ in 3T3-L1 adipocytes:: Roles as a PPARγ ligand [J].
Cho, MC ;
Lee, WS ;
Hong, JT ;
Park, SW ;
Moon, DC ;
Paik, SG ;
Yoon, DY .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 242 (1-2) :96-102
[8]   Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders [J].
Cho, Min-Chul ;
Lee, Kyoung ;
Paik, Sang-Gi ;
Yoon, Do-Young .
PPAR RESEARCH, 2008, 2008
[9]   Dietary phenolics: chemistry, bioavailability and effects on health [J].
Crozier, Alan ;
Jaganath, Indu B. ;
Clifford, Michael N. .
NATURAL PRODUCT REPORTS, 2009, 26 (08) :1001-1043
[10]   Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites [J].
De Angelis, M ;
Stossi, F ;
Waibel, M ;
Katzenellenbogen, BS ;
Katzenellenbogen, JA .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (23) :6529-6542